XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 33,480,365      
Balance at Dec. 31, 2019 $ 33,481 $ 111,824,859 $ (91,724,078) $ 20,134,262
Stock-based compensation expense 0 304,824 0 304,824
Net loss $ 0 0 (5,684,038) (5,684,038)
Sale of common stock and warrants, net of issuance costs (in shares) 11,428,572      
Sale of common stock and warrants, net of issuance costs $ 11,429 10,330,202 0 10,341,631
Issuance of common stock upon exercise of warrants (in shares) 19,089,361      
Issuance of common stock upon exercise of warrants $ 19,089 7,760,887 0 7,779,976
Balance (in shares) at Jun. 30, 2020 63,998,298      
Balance at Jun. 30, 2020 $ 63,999 130,220,772 (97,408,116) 32,876,655
Balance (in shares) at Mar. 31, 2020 34,604,436      
Balance at Mar. 31, 2020 $ 34,605 112,149,913 (94,282,893) 17,901,625
Stock-based compensation expense 0 113,444 0 113,444
Net loss $ 0 0 (3,125,223) (3,125,223)
Sale of common stock and warrants, net of issuance costs (in shares) 11,428,572      
Sale of common stock and warrants, net of issuance costs $ 11,429 10,330,202 0 10,341,631
Issuance of common stock upon exercise of warrants (in shares) 17,965,290      
Issuance of common stock upon exercise of warrants $ 17,965 7,627,213 0 7,645,178
Balance (in shares) at Jun. 30, 2020 63,998,298      
Balance at Jun. 30, 2020 $ 63,999 130,220,772 (97,408,116) 32,876,655
Balance (in shares) at Dec. 31, 2020 64,015,441      
Balance at Dec. 31, 2020 $ 64,016 130,659,550 (105,909,384) 24,814,182
Stock-based compensation expense 0 478,560 0 478,560
Net loss $ 0 0 (8,421,892) (8,421,892)
Sale of common stock and warrants, net of issuance costs (in shares) 33,658,538      
Sale of common stock and warrants, net of issuance costs $ 33,658 31,060,644 0 31,094,302
Issuance of common stock upon exercise of warrants (in shares) 4,230,000      
Issuance of common stock upon exercise of warrants $ 4,230 2,197,220 0 2,201,450
Balance (in shares) at Jun. 30, 2021 101,903,979      
Balance at Jun. 30, 2021 $ 101,904 164,395,974 (114,331,276) 50,166,602
Balance (in shares) at Mar. 31, 2021 101,903,979      
Balance at Mar. 31, 2021 $ 101,904 164,098,694 (110,553,303) 53,647,295
Stock-based compensation expense 0 297,280 0 297,280
Net loss $ 0 0 (3,777,973) (3,777,973)
Balance (in shares) at Jun. 30, 2021 101,903,979      
Balance at Jun. 30, 2021 $ 101,904 $ 164,395,974 $ (114,331,276) $ 50,166,602